Guangming Yang

Prof. Guangming Yang

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
YMYuhui Mi
Yuhui Mi
LZLei Zhong
Lei Zhong
SLSaijian Lu
Saijian Lu
PHPo Hu
Po Hu
YPYang Pan
Yang Pan
Guangming YangGuangming Yang
Guangming Yang

16 May 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
QWQinhang Wu
Qinhang Wu
XMXuelin Ma
Xuelin Ma
ZJZhuolin Jin
Zhuolin Jin
RNRuijun Ni
Ruijun Ni
YPYang Pan
Yang Pan
Guangming YangGuangming Yang
Guangming Yang

11 December 2024 in Aging Cell
Verified
Journal Article
Open access
TZTian‐Yi Zhu
Tian‐Yi Zhu
PHPo Hu
Po Hu
YMYu‐Hui Mi
Yu‐Hui Mi
JZJun‐Li Zhang
Jun‐Li Zhang
AXAn‐Na Xu
An‐Na Xu
YPYang Pan
Yang Pan
While previous research has demonstrated the therapeutic efficacy of telomerase reverse transcriptase (TERT) overexpression using adeno‐associated virus and cytomegalovirus vectors to combat aging, the broader implications of TERT germline gene editing on the mammalian genome, proteomic composition, phenotypes, lifespan extension, and damage repair remain largely unexplored. In this study, we elucidate the functional properties of transgenic mice carrying the Tert transgene, guided by precise gene targeting into the Rosa26 locus via embryonic stem (ES) cells under the control of the elongation factor 1α (EF1α) promoter. The Tert knock‐in (TertKI) mice harboring the EF1α‐Tert gene displayed elevated telomerase activity, elongated telomeres, and extended lifespan, with no spontaneous genotoxicity or carcinogenicity. The TertKI mice showed also enhanced wound healing, characterized by significantly increased expression of Fgf7, Vegf, and collagen. Additionally, TertKI mice exhibited robust resistance to the progression of colitis induced by dextran sodium sulfate (DSS), accompanied by reduced expression of disease‐deteriorating genes. These findings foreshadow the potential of TertKI as an extraordinary rejuvenation force, promising not only longevity but also rejuvenation in skin and intestinal aging.

19 August 2022 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
PHPo Hu
Po Hu
PWPeng Wan
Peng Wan
AXAnna Xu
Anna Xu
BYBinghui Yan
Binghui Yan
CLChunmei Liu
Chunmei Liu
YPYang Pan
Yang Pan

13 June 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
TZTianhui Zhou
Tianhui Zhou
YZYingying Zhang
Yingying Zhang
YLYuqing Lu
Yuqing Lu
ZSZhaodong Sun
Zhaodong Sun
DWDehui Wang
Dehui Wang
YPYang Pan
Yang Pan
Objective: Existing clinical data suggest that Huaier granules effectively improve the condition of PLC patients. However, their specific efficacy and safety in PLC patients remain unclear. This study aimed to investigate the effects of Huaier granules as an adjunctive therapy for PLC patients. Methods: This cohort study includes 4577 PLC patients, with data retrieved up to 2024. The patients were divided into the Huaier group (n = 2404) and a control group (n = 2173), and the treatment effects and safety between the two groups were compared. Review Manager 5.3 was used to analyze the clinical data. The fixed-effects and random-effects models were adopted. Stata 17.0 was used for sensitivity and bias analyses to evaluate publication bias. Results: Heterogeneity testing and analysis using a random-effects model showed that the combination of Huaier granules and conventional treatment significantly reduced the recurrence rate (OR = 0.65, 95% CI 0.50–0.85, p = 0.002) and improved the one-year survival rate (OR = 0.79, 95% CI 0.65–0.96, p = 0.02). Huaier granules also improved quality of life, reduced AFP levels (p < 0.00001), and significantly impacted immune function by altering the levels of the T lymphocyte subtypes CD3+, CD4+, CD8+ and the CD4+/CD8+ ratio. When Huaier granules were used in combination with other medications, no significant changes in side effects were observed. Conclusions: Huaier combination therapy shows good therapeutic efficacy and safety in PLC patients. However, this conclusion needs to be further validated through prospective clinical studies.

29 June 2023 in Molecules
Verified
Journal Article
Open access
PDF file
XWXinzhu Wang
Xinzhu Wang
ZWZhenhuan Wei
Zhenhuan Wei
PHPo Hu
Po Hu
WXWeibo Xia
Weibo Xia
ZLZhixin Liao
Zhixin Liao
YPYang Pan
Yang Pan
Liver cancer continues to be a focus of scientific research due to its low five-year survival rate. One of its main core issues is the high metastasis of cells, for which there is no effective treatment. Neferine was originally isolated from Plumula nelumbinis and demonstrated to have a good antitumor effect. In order to extract high-purity Neferine in a more efficient and environmentally friendly manner, response surface methodology (RSM) was used to optimize the isolation and purification procedures in this study. The extract conditions of a 7:3 ratio for the eluent of dichloromethane: methanol, 1:60 for the mass ratio of the extract amount: silica gel, and 3 mL/min of the elution flow rate were shown to be the optimal conditions. These conditions resulted in the highest yield of 6.13 mg per 66.60 mg of starting material, with productivity of 8.76% and purity of 87.04%. Compared with the previous methods, this method can prepare Neferine in large quantities more quickly. We subsequently evaluated the antitumor activity of the purified Neferine against HepG2 hepatic cancer cells. The purified Neferine was found to inhibit the proliferation of HepG2 cells through the CCK-8 assay, with an IC50 of 33.80 μM in 24 h, 29.47 μM in 48 h, 24.35 μM in 72 h and 2.78 μM in 96 h of treatment. Neferine at a concentration of 3 μM could significantly inhibit the migration and invasion abilities of the HepG2 cells in vitro. We also explored the mechanism of action of Neferine via Western blot. We showed that Neferine could reduce RhoA expression by effectively inhibiting the phosphorylation of MYPT1, thereby effectively exerting anti-metastasis activity against HepG2 cells. Thus, we have optimized the isolation procedures for highly pure Neferine by response surface methodology (RSM) in this study, and purified Neferine is shown to play an essential role in the anti-metastasis process of liver cancer cells. The Neferine purification procedure may make a wide contribution to the follow-up development of other anti-metastasis lead compounds.